Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy

Vaccine

Volumn 34, Issue 1, 2016, Pages 151-159

  Hoang, Ha Thi Thu ^b   Leuridan, Elke ^a   Maertens, Kirsten ^a   Nguyen, Trung Dac ^b   Hens, Niel ^a,d   Vu, Ngoc Ha ^e   Caboré, Raissa Nadège ^c   Duong, Hong Thi ^b   Huygen, Kris ^c   Van Damme, Pierre ^a   Dang, Anh Duc ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

^e VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

Author keywords

Maternal antibodies; Pertussis; Pregnancy; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; PERTACTIN; PERTUSSIS TOXIN; TETANUS TOXOID; BACTERIUM ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; PERTUSSIS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; TETANUS PROPHYLAXIS; UMBILICAL CORD BLOOD; BLOOD; DISEASE TRANSMISSION; IMMUNIZATION; INFANT; MALE; NEWBORN; PASSIVE IMMUNIZATION; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIET NAM; WHOOPING COUGH; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE TRANSMISSION, INFECTIOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; TREATMENT OUTCOME; VIETNAM; WHOOPING COUGH; YOUNG ADULT;

EID: 84949723756     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.098     Document Type: Article

References (42)

1. WHO Pertussis vaccines: WHO position paper. Releve epidemiologique hebdomadaire 2010, 85:385-400. (Section d'hygiene du Secretariat de la Societe des Nations[[nl]]Health Section of the Secretariat of the League of Nations).
2. Muloiwa R., Kagina B.M., Engel M.E., Hussey G.D. The burden of pertussis in low- and middle-income countries since the inception of the expanded programme on immunization (EPI) in 1974: a systematic review protocol. Syst Rev 2015, 4:62.
3. WHO Immunization, vaccines and biologicals: pertussis 2014, Available from 〈http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance:type/en/〉 (accessed on 08/10/2015).
4. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005, 133:159-171.
5. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005, 24:S58-S61.
6. Crowcroft N.S., Pebody R.G. Recent developments in pertussis. Lancet 2006, 367:1926-1936.
7. Mulholland K. Measles and pertussis in developing countries with good vaccine coverage. Lancet 1995, 345:305-307.
8. WHO Revised guidance on the choice of pertussis vaccines: July 2014 2014, (WER 2014, 89, 337-44).
9. Leuridan E., Goeyvaerts N., Hens N., Hutse V., Van Damme P. Maternal mumps antibodies in a cohort of children up to the age of 1 year. Eur J Pediatr 2012, 171:1167-1173.
10. De Schutter S., Maertens K., Baerts L., De Meester I., Van Damme P., Leuridan E. Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women. Pediatr Infect Dis J 2015, 34:e149-e152.
11. Healy C.M., Munoz F.M., Rench M.A., Halasa N.B., Edwards K.M., Baker C.J. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004, 190:335-340.
12. Linder N., Tallen-Gozani E., German B., Duvdevani P., Ferber A., Sirota L. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status. Vaccine 2004, 22:1509-1514.
13. Minville V., Zetlaoui P.J., Fessenmeyer C., Benhamou D. Ultrasound guidance for difficult lateral popliteal catheter insertion in a patient with peripheral vascular disease. Reg Anesth Pain Med 2004, 29:368-370.
14. Lindsey B., Kampmann B., Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis 2013, 26:248-253.
15. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obst Gynecol 2011, 204:334 e1-e3345.
16. Hardy-Fairbanks A.J., Pan S.J., Decker M.D., Johnson D.R., Greenberg D.P., Kirkland K.B., et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013, 32:1257-1260.
17. Vilajeliu A., Gonce A., Lopez M., Costa J., Rocamora L., Rios J., et al. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine 2015, 33:1056-1062.
18. Ministry of Health Vietnam EPI report of the Ministry of Health. 25 Years expanded program on immunization 2012.
19. Hoang Thi Thu H., Nguyen T.T., Pham T.H., Luong M.H., Nguyen T.A.X., Hoang T.B.N., et al. Direct PCR for detection of Bordetella pertussis from clinical specimens in Vietnam. J Prevent Med 2014, 11(160):8-13.
20. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17:1055-1065.
21. Agresti A. Categorical data analysis 2002, Wiley, New York, NY. 2nd ed.
22. Little R., Rubin D. Statistical analysis with missing data 1987, Wiley, Hoboken, New Jersey.
23. Breiman L. Random forests. Mach Learn 2001, 45:5-32.
24. Theeten H., Hens N., Vandermeulen C., Depoorter A.M., Roelants M., Aerts M., et al. Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey. Vaccine 2007, 25:4940-4948.
25. Sanofi Pasteur Limited C Summary of product characteristics Adacel 2011.
26. Munoz F.M., Bond N.H., Maccato M., Pinell P., Hammill H.A., Swamy G.K., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014, 311:1760-1769.
27. Donegan K., King B., Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014, 349:g4219.
28. Nguyen D.T., Van Damme D.D., Nguyen P., Duong V.C., Goossens T.H., Theeten H., et al. Coverage of the expanded programme on immunization in Vietnam: results from 2 cluster surveys and routine reports. Hum Vaccin Immunother 2015, 11(6):1526-1533.
29. Leuridan E., Hens N., Peeters N., de Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011, 30:608-610.
30. Huygen K., Cabore R.N., Maertens K., Van Damme P., Leuridan E. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Vaccine 2015, 33:4117-4123.
31. Diepolder H.M. Can specific heterologous immunity boost hepatitis B vaccine responses. J Infect Dis 2008, 198:297-298.
32. Leuridan E., Hens N., Hutse V., Aerts M., Van Damme P. Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine 2011, 29:2222-2226.
33. Caceres V.M., Strebel P.M., Sutter R.W. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 2000, 31:110-119.
34. de Voer R.M., van der Klis F.R., Nooitgedagt J.E., Versteegh F.G., van Huisseling J.C., van Rooijen D.M., et al. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis 2009, 49:58-64. (an official publication of the Infectious Diseases Society of America).
35. Leuridan E., Hens N., Hutse V., Ieven M., Aerts M., Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. Br Med J 2010, 340:c1626.
36. Englund J.A., Anderson E.L., Reed G.F., Decker M.D., Edwards K.M., Pichichero M.E., et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96:580-584.
37. Sako W.T.W., Witt D.B., et al. Early immunization against pertussis with alum precipitated vaccine. JAMA 1945, 127:379-383.
38. Van Rie A., Wendelboe A.M., Englund J.A. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005, 24:S62-S65.
39. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990, 161:487-492.
40. Saffar M.J., Ajami A., Khalilian A.R., Qaheri A., Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr 2007, 44:916-918.
41. Leuridan E., Hoang T.T.H., Maertens K., Nguyen D.T., Duong T.H., Caboré R.N., et al. Pertussis antibody responses in maternal and cord blood samples after vaccination during pregnancy: a Belgian-Vietnamese collaboration. Poster 0364 at ESPID 2014.
42. Frew P.M., Saint-Victor D.S., Isaacs M.B., Kim S., Swamy G.K., Sheffield J.S., et al. Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices. Clin Infect Dis 2014, 59(Suppl. 7):S400-S407. (an official publication of the Infectious Diseases Society of America).